Industry Research Reports

Home > Reports > Medical Devices & Consumables > Clinical Mass Spectrometry- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Clinical Mass Spectrometry- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Devices & Consumables

Published: 2024-10-09

Pages: 110 Pages

Report ld: 3337621

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Mass spectrometry is an analytic technique with high specificity and a growing presence in laboratory medicine. Various types of mass spectrometers are being used in an increasing number of clinical laboratories around the world, and, as a result, significant improvements in assay performance are occurring rapidly in areas such as toxicology, endocrinology, and biochemical genetics. Clinical mass spectrometry uses the mass spectrometry technology for diagnostic purposes. Employed by medical labs, clinical mass spectrometry is used to diagnose metabolism deficiencies, to determine whether biomarkers or enzymes are present, and for toxicology testing.

The global market for Clinical Mass Spectrometry was estimated to be worth US$ 925 million in 2023 and is forecast to a readjusted size of US$ 1798 million by 2030 with a CAGR of 10.1% during the forecast period 2024-2030.

Clinical Mass Spectrometry Market Size

M= millions and B=billions

Clinical Mass Spectrometry Market Drivers:
Rising Demand for Personalized Medicine: The increasing focus on personalized medicine in diagnosing and treating diseases is driving the demand for clinical mass spectrometry. Its ability to accurately analyze biomarkers, metabolites, and proteins makes it a key tool in personalized healthcare.

Technological Advancements: Innovations in mass spectrometry, such as higher sensitivity, faster analysis, and miniaturization, have expanded its clinical applications, improving diagnostic accuracy and speeding up workflows in laboratories.

Growing Prevalence of Chronic Diseases: The rising incidence of chronic diseases like cancer, cardiovascular disorders, and metabolic conditions has increased the need for precise diagnostic tools, further propelling the adoption of mass spectrometry in clinical settings.

Expanding Use in Clinical Diagnostics: Mass spectrometry is being increasingly applied in clinical diagnostics, including newborn screening, therapeutic drug monitoring, and toxicology testing, due to its accuracy, sensitivity, and ability to detect low-abundance molecules.

Clinical Mass Spectrometry Market Challenges:
High Equipment and Operational Costs: Clinical mass spectrometers are expensive to purchase and maintain, limiting their adoption, especially in smaller laboratories or in low- and middle-income countries where budgets are constrained.

Requirement for Skilled Personnel: The operation and interpretation of mass spectrometry data require highly trained professionals. A shortage of skilled personnel in many regions can hinder the widespread use of this technology.

Complexity and Time-Intensive Nature of the Technique: While mass spectrometry provides highly accurate results, the complexity of sample preparation and the time required for analysis can be a limiting factor in high-throughput clinical settings.

Regulatory Barriers: The approval process for new mass spectrometry-based diagnostic tests can be slow due to stringent regulatory requirements, delaying the introduction of innovative solutions into the clinical market.

Global clinical mass spectrometry key players include Danaher, Bruker, Thermo Fisher, Agilent, Waters, etc. Global top 5 manufacturers hold a share about 80%. North America is the largest market, with a share about 40%, followed by Europe, with a share about 34%.In terms of product, LC-MS is the largest segment, with a share over 75%. And in terms of application, the largest application is clinical diagnostics, followed by clinical research.

This report aims to provide a comprehensive presentation of the global market for Clinical Mass Spectrometry, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Clinical Mass Spectrometry by region & country, by Type, and by Application.

The Clinical Mass Spectrometry market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Mass Spectrometry.

Market Segmentation

Report Metric
Details
Report Title
Clinical Mass Spectrometry- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 1798 million
CAGR(2024-2030)
10.1%
Market Size Available for Years
2019-2030
Global Clinical Mass Spectrometry Companies Covered
Danaher, Bruker, Agilent, Thermo Fisher, Waters, Shidmazu, Perkin Elmer
Global Clinical Mass Spectrometry Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Clinical Mass Spectrometry Market, Segment by Type
LC-MS

MALDI-TOF MS

Other
Global Clinical Mass Spectrometry Market, Segment by Application
Clinical Diagnostics

Clinical Research
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Clinical Mass Spectrometry manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Clinical Mass Spectrometry in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Clinical Mass Spectrometry in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

 1 Market Overview
    1.1 Clinical Mass Spectrometry Product Introduction
    1.2 Global Clinical Mass Spectrometry Market Size Forecast
        1.2.1 Global Clinical Mass Spectrometry Sales Value (2019-2030)
        1.2.2 Global Clinical Mass Spectrometry Sales Volume (2019-2030)
        1.2.3 Global Clinical Mass Spectrometry Sales Price (2019-2030)
    1.3 Clinical Mass Spectrometry Market Trends & Drivers
        1.3.1 Clinical Mass Spectrometry Industry Trends
        1.3.2 Clinical Mass Spectrometry Market Drivers & Opportunity
        1.3.3 Clinical Mass Spectrometry Market Challenges
        1.3.4 Clinical Mass Spectrometry Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Clinical Mass Spectrometry Players Revenue Ranking (2023)
    2.2 Global Clinical Mass Spectrometry Revenue by Company (2019-2024)
    2.3 Global Clinical Mass Spectrometry Players Sales Volume Ranking (2023)
    2.4 Global Clinical Mass Spectrometry Sales Volume by Company Players (2019-2024)
    2.5 Global Clinical Mass Spectrometry Average Price by Company (2019-2024)
    2.6 Key Manufacturers Clinical Mass Spectrometry Manufacturing Base and Headquarters
    2.7 Key Manufacturers Clinical Mass Spectrometry Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Clinical Mass Spectrometry
    2.9 Clinical Mass Spectrometry Market Competitive Analysis
        2.9.1 Clinical Mass Spectrometry Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Clinical Mass Spectrometry Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Mass Spectrometry as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 LC-MS
        3.1.2 MALDI-TOF MS
        3.1.3 Other
    3.2 Global Clinical Mass Spectrometry Sales Value by Type
        3.2.1 Global Clinical Mass Spectrometry Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Clinical Mass Spectrometry Sales Value, by Type (2019-2030)
        3.2.3 Global Clinical Mass Spectrometry Sales Value, by Type (%) (2019-2030)
    3.3 Global Clinical Mass Spectrometry Sales Volume by Type
        3.3.1 Global Clinical Mass Spectrometry Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Clinical Mass Spectrometry Sales Volume, by Type (2019-2030)
        3.3.3 Global Clinical Mass Spectrometry Sales Volume, by Type (%) (2019-2030)
    3.4 Global Clinical Mass Spectrometry Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Clinical Diagnostics
        4.1.2 Clinical Research
    4.2 Global Clinical Mass Spectrometry Sales Value by Application
        4.2.1 Global Clinical Mass Spectrometry Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Clinical Mass Spectrometry Sales Value, by Application (2019-2030)
        4.2.3 Global Clinical Mass Spectrometry Sales Value, by Application (%) (2019-2030)
    4.3 Global Clinical Mass Spectrometry Sales Volume by Application
        4.3.1 Global Clinical Mass Spectrometry Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Clinical Mass Spectrometry Sales Volume, by Application (2019-2030)
        4.3.3 Global Clinical Mass Spectrometry Sales Volume, by Application (%) (2019-2030)
    4.4 Global Clinical Mass Spectrometry Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Clinical Mass Spectrometry Sales Value by Region
        5.1.1 Global Clinical Mass Spectrometry Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Clinical Mass Spectrometry Sales Value by Region (2019-2024)
        5.1.3 Global Clinical Mass Spectrometry Sales Value by Region (2025-2030)
        5.1.4 Global Clinical Mass Spectrometry Sales Value by Region (%), (2019-2030)
    5.2 Global Clinical Mass Spectrometry Sales Volume by Region
        5.2.1 Global Clinical Mass Spectrometry Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Clinical Mass Spectrometry Sales Volume by Region (2019-2024)
        5.2.3 Global Clinical Mass Spectrometry Sales Volume by Region (2025-2030)
        5.2.4 Global Clinical Mass Spectrometry Sales Volume by Region (%), (2019-2030)
    5.3 Global Clinical Mass Spectrometry Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Clinical Mass Spectrometry Sales Value, 2019-2030
        5.4.2 North America Clinical Mass Spectrometry Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Clinical Mass Spectrometry Sales Value, 2019-2030
        5.5.2 Europe Clinical Mass Spectrometry Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Clinical Mass Spectrometry Sales Value, 2019-2030
        5.6.2 Asia Pacific Clinical Mass Spectrometry Sales Value by Region (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Clinical Mass Spectrometry Sales Value, 2019-2030
        5.7.2 South America Clinical Mass Spectrometry Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Clinical Mass Spectrometry Sales Value, 2019-2030
        5.8.2 Middle East & Africa Clinical Mass Spectrometry Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Clinical Mass Spectrometry Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Clinical Mass Spectrometry Sales Value
        6.2.1 Key Countries/Regions Clinical Mass Spectrometry Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Clinical Mass Spectrometry Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Clinical Mass Spectrometry Sales Value, 2019-2030
        6.3.2 United States Clinical Mass Spectrometry Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Clinical Mass Spectrometry Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Clinical Mass Spectrometry Sales Value, 2019-2030
        6.4.2 Europe Clinical Mass Spectrometry Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Clinical Mass Spectrometry Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Clinical Mass Spectrometry Sales Value, 2019-2030
        6.5.2 China Clinical Mass Spectrometry Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Clinical Mass Spectrometry Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Clinical Mass Spectrometry Sales Value, 2019-2030
        6.6.2 Japan Clinical Mass Spectrometry Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Clinical Mass Spectrometry Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Clinical Mass Spectrometry Sales Value, 2019-2030
        6.7.2 South Korea Clinical Mass Spectrometry Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Clinical Mass Spectrometry Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Clinical Mass Spectrometry Sales Value, 2019-2030
        6.8.2 Southeast Asia Clinical Mass Spectrometry Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Clinical Mass Spectrometry Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Clinical Mass Spectrometry Sales Value, 2019-2030
        6.9.2 India Clinical Mass Spectrometry Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Clinical Mass Spectrometry Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Danaher
        7.1.1 Danaher Company Information
        7.1.2 Danaher Introduction and Business Overview
        7.1.3 Danaher Clinical Mass Spectrometry Sales, Revenue, Price and Gross Margin (2019-2024)
        7.1.4 Danaher Clinical Mass Spectrometry Product Offerings
        7.1.5 Danaher Recent Development
    7.2 Bruker
        7.2.1 Bruker Company Information
        7.2.2 Bruker Introduction and Business Overview
        7.2.3 Bruker Clinical Mass Spectrometry Sales, Revenue, Price and Gross Margin (2019-2024)
        7.2.4 Bruker Clinical Mass Spectrometry Product Offerings
        7.2.5 Bruker Recent Development
    7.3 Agilent
        7.3.1 Agilent Company Information
        7.3.2 Agilent Introduction and Business Overview
        7.3.3 Agilent Clinical Mass Spectrometry Sales, Revenue, Price and Gross Margin (2019-2024)
        7.3.4 Agilent Clinical Mass Spectrometry Product Offerings
        7.3.5 Agilent Recent Development
    7.4 Thermo Fisher
        7.4.1 Thermo Fisher Company Information
        7.4.2 Thermo Fisher Introduction and Business Overview
        7.4.3 Thermo Fisher Clinical Mass Spectrometry Sales, Revenue, Price and Gross Margin (2019-2024)
        7.4.4 Thermo Fisher Clinical Mass Spectrometry Product Offerings
        7.4.5 Thermo Fisher Recent Development
    7.5 Waters
        7.5.1 Waters Company Information
        7.5.2 Waters Introduction and Business Overview
        7.5.3 Waters Clinical Mass Spectrometry Sales, Revenue, Price and Gross Margin (2019-2024)
        7.5.4 Waters Clinical Mass Spectrometry Product Offerings
        7.5.5 Waters Recent Development
    7.6 Shidmazu
        7.6.1 Shidmazu Company Information
        7.6.2 Shidmazu Introduction and Business Overview
        7.6.3 Shidmazu Clinical Mass Spectrometry Sales, Revenue, Price and Gross Margin (2019-2024)
        7.6.4 Shidmazu Clinical Mass Spectrometry Product Offerings
        7.6.5 Shidmazu Recent Development
    7.7 Perkin Elmer
        7.7.1 Perkin Elmer Company Information
        7.7.2 Perkin Elmer Introduction and Business Overview
        7.7.3 Perkin Elmer Clinical Mass Spectrometry Sales, Revenue, Price and Gross Margin (2019-2024)
        7.7.4 Perkin Elmer Clinical Mass Spectrometry Product Offerings
        7.7.5 Perkin Elmer Recent Development

 8 Industry Chain Analysis
    8.1 Clinical Mass Spectrometry Industrial Chain
    8.2 Clinical Mass Spectrometry Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Clinical Mass Spectrometry Sales Model
        8.5.2 Sales Channel
        8.5.3 Clinical Mass Spectrometry Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

List of Tables
 Table 1. Clinical Mass Spectrometry Market Trends
 Table 2. Clinical Mass Spectrometry Market Drivers & Opportunity
 Table 3. Clinical Mass Spectrometry Market Challenges
 Table 4. Clinical Mass Spectrometry Market Restraints
 Table 5. Global Clinical Mass Spectrometry Revenue by Company (2019-2024) & (US$ Million)
 Table 6. Global Clinical Mass Spectrometry Revenue Market Share by Company (2019-2024)
 Table 7. Global Clinical Mass Spectrometry Sales Volume by Company (2019-2024) & (K Units)
 Table 8. Global Clinical Mass Spectrometry Sales Volume Market Share by Company (2019-2024)
 Table 9. Global Market Clinical Mass Spectrometry Price by Company (2019-2024) & (USD/Unit)
 Table 10. Key Manufacturers Clinical Mass Spectrometry Manufacturing Base and Headquarters
 Table 11. Key Manufacturers Clinical Mass Spectrometry Product Type
 Table 12. Key Manufacturers Time to Begin Mass Production of Clinical Mass Spectrometry
 Table 13. Global Clinical Mass Spectrometry Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Mass Spectrometry as of 2023)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Clinical Mass Spectrometry Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
 Table 17. Global Clinical Mass Spectrometry Sales Value by Type (2019-2024) & (US$ Million)
 Table 18. Global Clinical Mass Spectrometry Sales Value by Type (2025-2030) & (US$ Million)
 Table 19. Global Clinical Mass Spectrometry Sales Market Share in Value by Type (2019-2024)
 Table 20. Global Clinical Mass Spectrometry Sales Market Share in Value by Type (2025-2030)
 Table 21. Global Clinical Mass Spectrometry Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
 Table 22. Global Clinical Mass Spectrometry Sales Volume by Type (2019-2024) & (K Units)
 Table 23. Global Clinical Mass Spectrometry Sales Volume by Type (2025-2030) & (K Units)
 Table 24. Global Clinical Mass Spectrometry Sales Market Share in Volume by Type (2019-2024)
 Table 25. Global Clinical Mass Spectrometry Sales Market Share in Volume by Type (2025-2030)
 Table 26. Global Clinical Mass Spectrometry Price by Type (2019-2024) & (USD/Unit)
 Table 27. Global Clinical Mass Spectrometry Price by Type (2025-2030) & (USD/Unit)
 Table 28. Global Clinical Mass Spectrometry Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
 Table 29. Global Clinical Mass Spectrometry Sales Value by Application (2019-2024) & (US$ Million)
 Table 30. Global Clinical Mass Spectrometry Sales Value by Application (2025-2030) & (US$ Million)
 Table 31. Global Clinical Mass Spectrometry Sales Market Share in Value by Application (2019-2024)
 Table 32. Global Clinical Mass Spectrometry Sales Market Share in Value by Application (2025-2030)
 Table 33. Global Clinical Mass Spectrometry Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
 Table 34. Global Clinical Mass Spectrometry Sales Volume by Application (2019-2024) & (K Units)
 Table 35. Global Clinical Mass Spectrometry Sales Volume by Application (2025-2030) & (K Units)
 Table 36. Global Clinical Mass Spectrometry Sales Market Share in Volume by Application (2019-2024)
 Table 37. Global Clinical Mass Spectrometry Sales Market Share in Volume by Application (2025-2030)
 Table 38. Global Clinical Mass Spectrometry Price by Application (2019-2024) & (USD/Unit)
 Table 39. Global Clinical Mass Spectrometry Price by Application (2025-2030) & (USD/Unit)
 Table 40. Global Clinical Mass Spectrometry Sales Value by Region, (2019 VS 2023 VS 2030) & (US$ Million)
 Table 41. Global Clinical Mass Spectrometry Sales Value by Region (2019-2024) & (US$ Million)
 Table 42. Global Clinical Mass Spectrometry Sales Value by Region (2025-2030) & (US$ Million)
 Table 43. Global Clinical Mass Spectrometry Sales Value by Region (2019-2024) & (%)
 Table 44. Global Clinical Mass Spectrometry Sales Value by Region (2025-2030) & (%)
 Table 45. Global Clinical Mass Spectrometry Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
 Table 46. Global Clinical Mass Spectrometry Sales Volume by Region (2019-2024) & (K Units)
 Table 47. Global Clinical Mass Spectrometry Sales Volume by Region (2025-2030) & (K Units)
 Table 48. Global Clinical Mass Spectrometry Sales Volume by Region (2019-2024) & (%)
 Table 49. Global Clinical Mass Spectrometry Sales Volume by Region (2025-2030) & (%)
 Table 50. Global Clinical Mass Spectrometry Average Price by Region (2019-2024) & (USD/Unit)
 Table 51. Global Clinical Mass Spectrometry Average Price by Region (2025-2030) & (USD/Unit)
 Table 52. Key Countries/Regions Clinical Mass Spectrometry Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
 Table 53. Key Countries/Regions Clinical Mass Spectrometry Sales Value, (2019-2024) & (US$ Million)
 Table 54. Key Countries/Regions Clinical Mass Spectrometry Sales Value, (2025-2030) & (US$ Million)
 Table 55. Key Countries/Regions Clinical Mass Spectrometry Sales Volume, (2019-2024) & (K Units)
 Table 56. Key Countries/Regions Clinical Mass Spectrometry Sales Volume, (2025-2030) & (K Units)
 Table 57. Danaher Company Information
 Table 58. Danaher Introduction and Business Overview
 Table 59. Danaher Clinical Mass Spectrometry Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
 Table 60. Danaher Clinical Mass Spectrometry Product Offerings
 Table 61. Danaher Recent Development
 Table 62. Bruker Company Information
 Table 63. Bruker Introduction and Business Overview
 Table 64. Bruker Clinical Mass Spectrometry Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
 Table 65. Bruker Clinical Mass Spectrometry Product Offerings
 Table 66. Bruker Recent Development
 Table 67. Agilent Company Information
 Table 68. Agilent Introduction and Business Overview
 Table 69. Agilent Clinical Mass Spectrometry Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
 Table 70. Agilent Clinical Mass Spectrometry Product Offerings
 Table 71. Agilent Recent Development
 Table 72. Thermo Fisher Company Information
 Table 73. Thermo Fisher Introduction and Business Overview
 Table 74. Thermo Fisher Clinical Mass Spectrometry Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
 Table 75. Thermo Fisher Clinical Mass Spectrometry Product Offerings
 Table 76. Thermo Fisher Recent Development
 Table 77. Waters Company Information
 Table 78. Waters Introduction and Business Overview
 Table 79. Waters Clinical Mass Spectrometry Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
 Table 80. Waters Clinical Mass Spectrometry Product Offerings
 Table 81. Waters Recent Development
 Table 82. Shidmazu Company Information
 Table 83. Shidmazu Introduction and Business Overview
 Table 84. Shidmazu Clinical Mass Spectrometry Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
 Table 85. Shidmazu Clinical Mass Spectrometry Product Offerings
 Table 86. Shidmazu Recent Development
 Table 87. Perkin Elmer Company Information
 Table 88. Perkin Elmer Introduction and Business Overview
 Table 89. Perkin Elmer Clinical Mass Spectrometry Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
 Table 90. Perkin Elmer Clinical Mass Spectrometry Product Offerings
 Table 91. Perkin Elmer Recent Development
 Table 92. Key Raw Materials Lists
 Table 93. Raw Materials Key Suppliers Lists
 Table 94. Clinical Mass Spectrometry Downstream Customers
 Table 95. Clinical Mass Spectrometry Distributors List
 Table 96. Research Programs/Design for This Report
 Table 97. Key Data Information from Secondary Sources
 Table 98. Key Data Information from Primary Sources


List of Figures
 Figure 1. Clinical Mass Spectrometry Product Picture
 Figure 2. Global Clinical Mass Spectrometry Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 3. Global Clinical Mass Spectrometry Sales Value (2019-2030) & (US$ Million)
 Figure 4. Global Clinical Mass Spectrometry Sales Volume (2019-2030) & (K Units)
 Figure 5. Global Clinical Mass Spectrometry Sales Price (2019-2030) & (USD/Unit)
 Figure 6. Clinical Mass Spectrometry Report Years Considered
 Figure 7. Global Clinical Mass Spectrometry Players Revenue Ranking (2023) & (US$ Million)
 Figure 8. Global Clinical Mass Spectrometry Players Sales Volume Ranking (2023) & (US$ Million)
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Clinical Mass Spectrometry Revenue in 2023
 Figure 10. Clinical Mass Spectrometry Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 11. LC-MS Picture
 Figure 12. MALDI-TOF MS Picture
 Figure 13. Other Picture
 Figure 14. Global Clinical Mass Spectrometry Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
 Figure 15. Global Clinical Mass Spectrometry Sales Value Market Share by Type, 2023 & 2030
 Figure 16. Global Clinical Mass Spectrometry Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
 Figure 17. Global Clinical Mass Spectrometry Sales Volume Market Share by Type, 2023 & 2030
 Figure 18. Global Clinical Mass Spectrometry Price by Type (2019-2030) & (USD/Unit)
 Figure 19. Product Picture of Clinical Diagnostics
 Figure 20. Product Picture of Clinical Research
 Figure 21. Global Clinical Mass Spectrometry Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
 Figure 22. Global Clinical Mass Spectrometry Sales Value Market Share by Application, 2023 & 2030
 Figure 23. Global Clinical Mass Spectrometry Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
 Figure 24. Global Clinical Mass Spectrometry Sales Volume Market Share by Application, 2023 & 2030
 Figure 25. Global Clinical Mass Spectrometry Price by Application (2019-2030) & (USD/Unit)
 Figure 26. North America Clinical Mass Spectrometry Sales Value (2019-2030) & (US$ Million)
 Figure 27. North America Clinical Mass Spectrometry Sales Value by Country (%), 2023 VS 2030
 Figure 28. Europe Clinical Mass Spectrometry Sales Value, (2019-2030) & (US$ Million)
 Figure 29. Europe Clinical Mass Spectrometry Sales Value by Country (%), 2023 VS 2030
 Figure 30. Asia Pacific Clinical Mass Spectrometry Sales Value, (2019-2030) & (US$ Million)
 Figure 31. Asia Pacific Clinical Mass Spectrometry Sales Value by Region (%), 2023 VS 2030
 Figure 32. South America Clinical Mass Spectrometry Sales Value, (2019-2030) & (US$ Million)
 Figure 33. South America Clinical Mass Spectrometry Sales Value by Country (%), 2023 VS 2030
 Figure 34. Middle East & Africa Clinical Mass Spectrometry Sales Value, (2019-2030) & (US$ Million)
 Figure 35. Middle East & Africa Clinical Mass Spectrometry Sales Value by Country (%), 2023 VS 2030
 Figure 36. Key Countries/Regions Clinical Mass Spectrometry Sales Value (%), (2019-2030)
 Figure 37. Key Countries/Regions Clinical Mass Spectrometry Sales Volume (%), (2019-2030)
 Figure 38. United States Clinical Mass Spectrometry Sales Value, (2019-2030) & (US$ Million)
 Figure 39. United States Clinical Mass Spectrometry Sales Value by Type (%), 2023 VS 2030
 Figure 40. United States Clinical Mass Spectrometry Sales Value by Application (%), 2023 VS 2030
 Figure 41. Europe Clinical Mass Spectrometry Sales Value, (2019-2030) & (US$ Million)
 Figure 42. Europe Clinical Mass Spectrometry Sales Value by Type (%), 2023 VS 2030
 Figure 43. Europe Clinical Mass Spectrometry Sales Value by Application (%), 2023 VS 2030
 Figure 44. China Clinical Mass Spectrometry Sales Value, (2019-2030) & (US$ Million)
 Figure 45. China Clinical Mass Spectrometry Sales Value by Type (%), 2023 VS 2030
 Figure 46. China Clinical Mass Spectrometry Sales Value by Application (%), 2023 VS 2030
 Figure 47. Japan Clinical Mass Spectrometry Sales Value, (2019-2030) & (US$ Million)
 Figure 48. Japan Clinical Mass Spectrometry Sales Value by Type (%), 2023 VS 2030
 Figure 49. Japan Clinical Mass Spectrometry Sales Value by Application (%), 2023 VS 2030
 Figure 50. South Korea Clinical Mass Spectrometry Sales Value, (2019-2030) & (US$ Million)
 Figure 51. South Korea Clinical Mass Spectrometry Sales Value by Type (%), 2023 VS 2030
 Figure 52. South Korea Clinical Mass Spectrometry Sales Value by Application (%), 2023 VS 2030
 Figure 53. Southeast Asia Clinical Mass Spectrometry Sales Value, (2019-2030) & (US$ Million)
 Figure 54. Southeast Asia Clinical Mass Spectrometry Sales Value by Type (%), 2023 VS 2030
 Figure 55. Southeast Asia Clinical Mass Spectrometry Sales Value by Application (%), 2023 VS 2030
 Figure 56. India Clinical Mass Spectrometry Sales Value, (2019-2030) & (US$ Million)
 Figure 57. India Clinical Mass Spectrometry Sales Value by Type (%), 2023 VS 2030
 Figure 58. India Clinical Mass Spectrometry Sales Value by Application (%), 2023 VS 2030
 Figure 59. Clinical Mass Spectrometry Industrial Chain
 Figure 60. Clinical Mass Spectrometry Manufacturing Cost Structure
 Figure 61. Channels of Distribution (Direct Sales, and Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed

Mass spectrometry is an analytic technique with high specificity and a growing presence in laboratory medicine. Various types of mass spectrometers are being used in an increasing number of clinical laboratories around the world, and, as a result, significant improvements in assay performance are occurring rapidly in areas such as toxicology, endocrinology, and biochemical genetics. Clinical mass spectrometry uses the mass spectrometry technology for diagnostic purposes. Employed by medical labs, clinical mass spectrometry is used to diagnose metabolism deficiencies, to determine whether biomarkers or enzymes are present, and for toxicology testing.

The global market for Clinical Mass Spectrometry was estimated to be worth US$ 925 million in 2023 and is forecast to a readjusted size of US$ 1798 million by 2030 with a CAGR of 10.1% during the forecast period 2024-2030.

Clinical Mass Spectrometry Market Drivers:
Rising Demand for Personalized Medicine: The increasing focus on personalized medicine in diagnosing and treating diseases is driving the demand for clinical mass spectrometry. Its ability to accurately analyze biomarkers, metabolites, and proteins makes it a key tool in personalized healthcare.

Technological Advancements: Innovations in mass spectrometry, such as higher sensitivity, faster analysis, and miniaturization, have expanded its clinical applications, improving diagnostic accuracy and speeding up workflows in laboratories.

Growing Prevalence of Chronic Diseases: The rising incidence of chronic diseases like cancer, cardiovascular disorders, and metabolic conditions has increased the need for precise diagnostic tools, further propelling the adoption of mass spectrometry in clinical settings.

Expanding Use in Clinical Diagnostics: Mass spectrometry is being increasingly applied in clinical diagnostics, including newborn screening, therapeutic drug monitoring, and toxicology testing, due to its accuracy, sensitivity, and ability to detect low-abundance molecules.

Clinical Mass Spectrometry Market Challenges:
High Equipment and Operational Costs: Clinical mass spectrometers are expensive to purchase and maintain, limiting their adoption, especially in smaller laboratories or in low- and middle-income countries where budgets are constrained.

Requirement for Skilled Personnel: The operation and interpretation of mass spectrometry data require highly trained professionals. A shortage of skilled personnel in many regions can hinder the widespread use of this technology.

Complexity and Time-Intensive Nature of the Technique: While mass spectrometry provides highly accurate results, the complexity of sample preparation and the time required for analysis can be a limiting factor in high-throughput clinical settings.

Regulatory Barriers: The approval process for new mass spectrometry-based diagnostic tests can be slow due to stringent regulatory requirements, delaying the introduction of innovative solutions into the clinical market.

Global clinical mass spectrometry key players include Danaher, Bruker, Thermo Fisher, Agilent, Waters, etc. Global top 5 manufacturers hold a share about 80%. North America is the largest market, with a share about 40%, followed by Europe, with a share about 34%.In terms of product, LC-MS is the largest segment, with a share over 75%. And in terms of application, the largest application is clinical diagnostics, followed by clinical research.

This report aims to provide a comprehensive presentation of the global market for Clinical Mass Spectrometry, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Clinical Mass Spectrometry by region & country, by Type, and by Application.

The Clinical Mass Spectrometry market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Mass Spectrometry.

Market Segmentation

Industry: Medical Devices & Consumables

Published: 2024-10-09

Pages: 110 Pages

Report ld: 3337621

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 3950.00

Multi Users License

USD 5925.00

Corporate Users License